ArticleInternational health2019
Gender equity in mass drug administration for neglected tropical diseases: data from 16 countries.
Article in International health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Beyond Coverage: A Systematic Review and Thematic Analysis of Delivery, Compliance, Equity and Impact in Mass Deworming for Soil-Transmitted Helminths.Acta parasitologica · 2026Pooled it
- Coverage of community-wide mass drug administration platforms for soil-transmitted helminths in Benin, India, and Malawi: findings from the DeWorm3 project.Infectious diseases of poverty · 2024Trial
- Gender equity and social inclusion in mass drug administration for neglected tropical diseases in post-conflict South Sudan.Dialogues in health · 2026Article
- Inclusion in Neglected Tropical Disease Programmes: A Review of Inclusive Approaches for Control and Elimination.Healthcare (Basel, Switzerland) · 2025Review
- The changing neglected tropical disease landscape in Africa: implications for policy, practice, and strengthening health systems.Health affairs scholar · 2025Article
- Article
- "Our desire is to make this village intestinal worm free": Identifying determinants of high coverage of community-wide mass drug administration for soil transmitted helminths in Benin, India, and Malawi.PLoS neglected tropical diseases · 2024Article
- A conceptualisation of scale-up and sustainability of social innovations in global health: a narrative review and integrative framework for action.Global health action · 2023Review
- Synthesis of findings from the literature and a qualitative research study on the impacts of gender, disability, and ethnicity in Neglected Tropical Diseases programs.PLoS neglected tropical diseases · 2023Review
- Addressing neglected tropical diseases in Africa: A gender perspective.Health science reports · 2023Article
- Prevalence and risk distribution of schistosomiasis among adults in Madagascar: a cross-sectional study.Infectious diseases of poverty · 2023Article
- Contextual determinants of mass drug administration performance: Modelling fourteen years of lymphatic filariasis treatments in West Africa.PLoS neglected tropical diseases · 2023Article
- A novel theatre-based behaviour change approach for influencing community uptake of schistosomiasis control measures.Parasites & vectors · 2022Article
- Burden of Risk Factors for Cervical Cancer Among Women Living in East Africa: An Analysis of the Latest Demographic Health Surveys Conducted Between 2014 and 2017.JCO global oncology · 2021Article
- Prevalence of Schistosomiasis (S. mansoni and S. haematobium) and its association with gender of school age children in Ethiopia: A systematic review and meta-analysis.Parasite epidemiology and control · 2021Article
- Evaluating Equity and Coverage in Mass Drug Administration for Soil-Transmitted Helminth Infections among School-Age Children in the Hard-to-Reach Setting of Southern Ethiopia.Pediatric health, medicine and therapeutics · 2021Article
- Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.International health · 2020Article
- Gender differences in the perceived need for community-wide deworming: Formative qualitative research from the DeWorm3 study, India.PLoS neglected tropical diseases · 2020Article
- Impacts of host gender on Schistosoma mansoni risk in rural Uganda-A mixed-methods approach.PLoS neglected tropical diseases · 2020Article
- Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa.International health · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
27 authors at 12 institutions in 11 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGender equity in global health is a target of the Sustainable Development Goals and a requirement of just societies. Substantial progress has been made towards control and elimination of neglected tropical diseases (NTDs) via mass drug administration (MDA). However, little is known about whether MDA coverage is equitable. This study assesses the availability of gender-disaggregated data and whether systematic gender differences in MDA coverage exist.
methodsCoverage data were analyzed for 4784 district-years in 16 countries from 2012 through 2016. The percentage of districts reporting gender-disaggregated data was calculated and male-female coverage compared.
resultsReporting of gender-disaggregated coverage data improved from 32% of districts in 2012 to 90% in 2016. In 2016, median female coverage was 85.5% compared with 79.3% for males. Female coverage was higher than male coverage for all diseases. However, within-country differences exist, with 64 (3.3%) districts reporting male coverage >10 percentage points higher than female coverage.
conclusionsReporting of gender-disaggregated data is feasible. And NTD programs consistently achieve at least equal levels of coverage for women. Understanding gendered barriers to MDA for men and women remains a priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.